![Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design](https://pubs.acs.org/cms/10.1021/acs.cgd.1c01421/asset/images/medium/cg1c01421_0001.gif)
Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design
Analytics for US Patent No. 6969770, 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
![La Estructura 3d De Piracetam (que Se Vende Bajo Muchas Marcas) Es Una Droga Nootrópica En El Grupo De Los Racetams, Con El Nombre Químico De 2-oxo -1-pirrolidina Acetamida. Fotos, Retratos, Imágenes Y La Estructura 3d De Piracetam (que Se Vende Bajo Muchas Marcas) Es Una Droga Nootrópica En El Grupo De Los Racetams, Con El Nombre Químico De 2-oxo -1-pirrolidina Acetamida. Fotos, Retratos, Imágenes Y](https://previews.123rf.com/images/lculig/lculig1701/lculig170100184/69294082-la-estructura-3d-de-piracetam-que-se-vende-bajo-muchas-marcas-es-una-droga-nootr%C3%B3pica-en-el-grupo-de.jpg)
La Estructura 3d De Piracetam (que Se Vende Bajo Muchas Marcas) Es Una Droga Nootrópica En El Grupo De Los Racetams, Con El Nombre Químico De 2-oxo -1-pirrolidina Acetamida. Fotos, Retratos, Imágenes Y
![2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents | Journal of Medicinal Chemistry 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm501814x/asset/images/large/jm-2014-01814x_0016.jpeg)
2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents | Journal of Medicinal Chemistry
![1346602-09-2 | Oxiracetam-13C2,15N | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide-13C2,15N; Hydroxypiracetam-13C2,15N; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide-13C2,15N; CGP 21690-13C2,15N; CGP 21690E-13C2,15N; CT 848-13C2,15N; 4-Hydroxy-2-oxo-1 ... 1346602-09-2 | Oxiracetam-13C2,15N | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide-13C2,15N; Hydroxypiracetam-13C2,15N; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide-13C2,15N; CGP 21690-13C2,15N; CGP 21690E-13C2,15N; CT 848-13C2,15N; 4-Hydroxy-2-oxo-1 ...](https://www.trc-canada.com/prod-img/O846907.png)
1346602-09-2 | Oxiracetam-13C2,15N | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide-13C2,15N; Hydroxypiracetam-13C2,15N; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide-13C2,15N; CGP 21690-13C2,15N; CGP 21690E-13C2,15N; CT 848-13C2,15N; 4-Hydroxy-2-oxo-1 ...
![US7902380B2 - Process for the preparation of (S)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-pyrrolidineacetamide - Google Patents US7902380B2 - Process for the preparation of (S)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-pyrrolidineacetamide - Google Patents](https://patentimages.storage.googleapis.com/3a/3c/00/5f122d4723663f/US07902380-20110308-C00004.png)
US7902380B2 - Process for the preparation of (S)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-pyrrolidineacetamide - Google Patents
![103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC 103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC](https://www.trc-canada.com/prod-img/L331505.png)
103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC
![7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC 7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC](https://www.trc-canada.com/prod-img/P500800.png)
7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC
![Anticonvulsant agent 1 (4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1- pyrrolidineacetamide) | MedChemExpress Anticonvulsant agent 1 (4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1- pyrrolidineacetamide) | MedChemExpress](https://file.medchemexpress.com/product_pic/hy-u00348.gif)